SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-19-000719
Filing Date
2019-08-21
Accepted
2019-08-21 09:47:29
Documents
1
Period of Report
2019-08-19

Document Format Files

Seq Description Document Type Size
1 matinasbio_fm4aug192019.html 4  
1 matinasbio_fm4aug192019.xml 4 3150
  Complete submission text file 0000905718-19-000719.txt   4560
Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Ende Eric J (Reporting) CIK: 0001494386 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 191041382

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations